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INTRODUCTION
While clinical features such as age and sex are 
important in differentiating pancreatic tumors, imaging 
features can be very informative for both the detection 
and characterization of lesions. For example, most solid 
pancreatic tumors are malignant or potentially malignant, 
so surgical resection should be initially considered as a 
curative treatment. On the other hand, cystic pancreatic 
lesions may be either benign or have malignant potential. 
Therefore, accurate diagnosis of pancreatic lesions is 
critical for management planning. However, accurate 
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characterization and differentiation are still challenging 
because of their morphologic overlap (1, 2). 
Multi-detector computed tomography (MDCT) is usually 
used as an initial imaging tool for evaluating pancreatic 
lesions and is an excellent modality for both detection 
and characterization. Once pancreatic lesions are found on 
MDCT, magnetic resonance imaging (MRI) and endoscopic 
ultrasound (EUS) can be used for further characterization 
(3, 4). MRI has been accepted as a useful imaging modality 
for evaluating cystic lesions due to its excellent soft tissue 
contrast. EUS is valuable for precisely demonstrating 
internal structures such as septa and mural nodules, thanks 
to its high spatial resolution (5). Classification schemes 
for pancreatic cystic tumors have been previously proposed 
based on the morphologic features of the lesions (1, 5). 
However, we suggest another modified classification system 
based on the imaging features of pancreatic tumors, with an 
emphasis on CT findings for better differential diagnosis and 
treatment planning. The correlation between the pathologic 
specimens to the imaging features is briefly described along 
the figures.
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Classification of the Pancreatic Tumors: 
Categorization Based on Gross Morphology and 
Malignant Potential
In this article, we classified pancreatic tumors into 
solid tumors, mixed cystic and solid lesions, unilocular 
cysts, multilocular cystic lesions, and microcystic lesions. 
This classification is based on the previously suggested 
classifications for pancreatic cystic tumors (1, 5). However, 
under the influence of the ovarian tumor classification of 
the International Ovarian Tumor Analysis (IOTA) group, we 
thought “solid tumors” should be included as a category in 
pancreatic tumor classification according to its morphologic 
features. Therefore we created a category for solid and 
cystic tumors. Multilocular cystic tumors were divided into 
either a lobulated, pleomorphic, or smooth shape with 
septation for better differentiation (Table 1). Because each 
pancreatic neoplasm has characteristic morphologic features 
and different malignant potential, this classification system 
of pancreatic tumors can be helpful in characterizing and 
managing the lesions (Fig. 1). Quite a number of potentially 
malignant cystic pancreatic tumors (e.g., mucinous cystic 
neoplasms [MCNs] or intraductal papillary mucinous 
neoplasms [IPMNs]), show typical morphologic features, 
allowing therapeutic planning to be determined based on 
imaging findings.
Solid Tumors
Although there are a wide variety of pancreatic 
neoplasms, the majority of them are epithelial tumors and 
90% of these are ductal adenocarcinomas and their variants 
(e.g., adenosquamous carcinomas and undifferentiated 
carcinomas). Ductal adenocarcinoma is highly invasive 
and often elicits a desmoplastic reaction. Typically, ductal 
adenocarcinoma is a hypoattenuating solid mass relative 
to the normally enhancing pancreatic parenchyma in the 
pancreatic and portal venous phases because of fibroblastic 
proliferation and decreased vascularity. Tumors in the head 
and body of the pancreas frequently cause pancreatic or 
biliary duct obstruction with upstream ductal dilatation 
and pancreatic parenchymal atrophy. Neoplasms originating 
Table 1. Classification of Pancreatic Tumors Based on Gross Morphology and Malignant Potential 
Morphologic Classification of Pancreatic Lesions Malignant Potential
Solid tumors
 Ductal adenocarcinoma Malignant
 Pancreatic endocrine tumor Malignant or potentially malignant
 Metastasis Malignant
Mixed cystic and solid Lesions
 Cystic change of pancreatic endocrine tumor Malignant or potentially malignant
 Solid pseudopapillary tumor Low grade malignant
 Cystic change of ductal carcinoma Malignant
 Cystic metastasis Malignant
Unilocular cysts
 Lymphoepithelial cyst Benign
 Mucinous cystic neoplasm Potentially malignant
 Intraductal papillary mucinous neoplasm (IPMN) Benign or potentially malignant
 Serous cystadenoma Benign
Multilocular cystic lesions
 a. Lobulated
Oligocystic serous cystadenoma Benign
 b. Pleomorphic cyst
Intraductal papillary mucinous neoplasm (branch duct type) From benign to malignant
 c. Smooth shape with septation
Mucinous cystic neoplasm Potentially malignant
Microcystic lesions
 Microcystic serous cystadenoma Benign
Korean J Radiol 12(6), Nov/Dec 2011kjronline.org 733
CT Findings and Pathologic Classification of Pancreatic Tumors
outside the exocrine ductal epithelium are rare. They 
include pancreatic endocrine tumors and metastasis. 
Pancreatic endocrine tumors are typically hyperattenuating 
in the arterial and venous phases on contrast-enhanced 
CT because of their rich capillary network, while most 
pancreatic metastases are hypodense except for those from 
renal cell carcinoma and melanoma (Fig. 2). Unlike ductal 
adenocarcinomas, pancreatic endocrine tumors are well 
demarcated and rarely result in pancreatic ductal dilatation. 
In addition, owing to their hypervascularity, the tumors 
intensely enhance on either contrast enhanced CT or MRI 
(6).
Mixed Cystic and Solid Lesions
This category includes true cystic tumors as well as 
solid neoplasm associated with a cystic component or 
cystic degeneration. Solid tumors associated with a cystic 
component include cystic pancreatic endocrine tumor 
(Fig. 3), solid pseudopapillary tumor (SPT), cystic change 
of ductal carcinoma, and metastasis (5). Usually a cystic 
pancreatic endocrine tumor is a single unilocular cyst 
that occupies the majority of the tumor. In rare cases, 
ductal adenocarcinoma with cystic change could also 
manifest as a unilocular cystic lesion (7). Cystic change of 
A. Solid
Lobulated Pleomorphic cystic Smooth shape with septation
B. Mixed Cystic and Solid
D. Multilocular Cystic E. Microcystic
C. Unilocular Cyst
Fig. 1. Morphologic subtypes of pancreatic lesions. 
Because each pancreatic neoplasm has different malignant 
potential, it is clinically valuable to determine characteristic 
imaging findings that can enable differentiation. We 
classified pancreatic tumors into solid tumors (A malignant 
or potentially malignant), mixed cystic and solid lesions 
(B malignant or potentially malignant), unilocular cysts (C 
benign or potentially malignant), multilocular cystic lesions 
(D benign or potentially malignant), and microcystic lesions 
(E benign). Multilocular cystic lesions are divided into three 
categories including lobulated (benign), pleomorphic (from 
benign to malignant), and smooth in shape with septation 
(potentially malignant). These figures are made by referring 
to previously suggested classification schema (5).
Fig. 2. 58-year-old woman with metastatic leiomyosarcoma manifesting as solid 
lesion.
A. Contrast-enhanced CT image during venous phase shows well-marginated, low attenuating 
solid tumor in pancreas (white arrow). B. Endoscopic US image depicts heterogeneously 
hypoechoic solid tumor (white arrow). Woman had multiple painless metastatic tumors in her 
stomach, chest, thigh and pancreas, which were too numerous to excise. Consequently, surgery 
was ruled out, and only chemotherapy was performed. C. Woman began to feel sick and mass 
increased in size at 1-year follow-up CT. Note metastatic nodule in subcutaneous layer (white 
arrow). D. Tumor was finally excised and appeared as whitish solid tumor in gross specimen and 
was confirmed as metastatic leiomyosarcoma (white arrow).
A
D
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ductal carcinoma commonly has low-attenuating regions 
consistent with necrosis, dilated duct or mucin pools. 
In comparison with cystic pancreatic endocrine tumor, 
cystic change of ductal carcinoma appears as relatively 
poor enhancement of solid portion and has irregular outer 
margin due to a desmoplastic reaction. On the other hand, 
when central necrosis is present in pancreatic endocrine 
tumor, enhancement of the non-necrotic portions is typical 
on contrast enhanced CT or MRI (6). SPT appears as a well-
demarcated mass with a fibrous capsule and varying amount 
of hemorrhage, necrosis, or calcification (8). Because all of 
these tumors are either malignant or have a high potential 
for being malignant, surgical resection is the treatment of 
choice. 
Unilocular Cysts
Unilocular cysts are probably the most difficult to 
manage because they are frequently small and consist 
of a broad-spectrum of benign to potentially malignant 
pathologies, including MCN (Fig. 4), IPMN, and serous 
cystadenoma. A unilocular cyst in a patient with a clinical 
history of pancreatitis is almost always a pseudocyst. 
Other less common unilocular cysts include simple cyst 
or lymphoepithelial cyst (Fig. 5). Although accurate 
characterization of unilocular cysts is challenging, CT 
findings, including the location in the pancreatic head, 
lobulated contour, absence of wall enhancement, and 
lack of mural nodule, are specific for the service of serous 
cystadenoma (9). The presence of peripheral tumoral 
calcification has a significant association with mucinous 
cystic neoplasms (10). Moreover, when differentiation is not 
possible at imaging, symptomatic patients can be further 
treated with EUS-guided cyst aspiration or surgical resection (5).
Multilocular Cystic Lesions
Multilocular cystic lesions can be divided into three 
Fig. 3. 40-year-old man with cystic change of islet cell tumor manifesting as mixed cystic and solid lesion.
A. Contrast enhanced CT image during arterial phase shows two unilocular cystic lesions with small solid components in tail of pancreas (white 
arrow). B. T2-weighted image shows cystic character of lesions (white arrow). C. Surgical specimen shows two predominantly cystic lesions with 
solid portion and small mural nodules. Microscopic examination revealed cystic change of islet cell tumors (black arrows).
A B C
Fig. 4. 57-year-old woman with mucinous cystic neoplasm manifesting as unilocular cyst.
A. Transverse contrast enhanced CT image during arterial phase shows unilocular cyst (white arrow) in body of pancreas. B. Endoscopic US image 
depicts cyst without solid portion or septation. C. Gross specimen reveals unilocular cystic lesions without septation or solid mural nodule (white 
arrow). Communication with pancreatic duct was not found. Tumor was confirmed as mucinous cystadenoma.
A B C
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categories: (a) lobulated; (b) pleomorphic, (c) smooth 
shape with septation (1, 5). A “lobulated” shape is defined 
as the shape of a simple closed curve that could not be 
described as the borders of the same circle, with or without 
internal septation and corresponding with oligocystic 
serous cystadenomas. A “pleomorphic” shape is defined as 
one containing three or more cysts, including more than 
one oval or tubular cyst, and is typical of branch duct type 
IPMNs. A “smooth shape with septation” is defined as a 
simple closed curve with the borders of the same circle, and 
this is a typical finding of MCNs (Fig. 6). 
The cystic tumors in this category are also difficult to be 
characterized because of their overlapping morphology. The 
differentiation of oligocystic serous cystadenoma from MCN 
is important because of the malignancy potential of the 
mucinous tumors. Oligocystic serous cystadenoma appears 
as a multicystic or lobulated cystic lesion with septation 
(Fig. 7), while MCN shows a smooth shape, with or without 
septations. Calcification in serous cystadenomas is typically 
central within the fibrous stroma, whereas MCN may have a 
peripheral eggshell calcification (1, 9).
A branch duct type or combined type IPMN can have the 
morphologic features of pleomorphic cysts. They arise from 
the epithelial lining of the pancreatic duct and typically 
produce a copious amount of mucin, which may cause ductal 
dilatation and obstruction resulting from mucus plugs. 
Histologically, IPMN represents a spectrum ranging from 
hyperplasia to carcinoma. Identification of a pleomorphic 
cyst that communicates with the main pancreatic duct is 
highly suggestive of a branch duct type or combined type 
IPMN (Fig. 8). Usually solid tumors, serous cystadenomas, 
and most mucinous cystic neoplasms do not show ductal 
communication. For predicting ductal communication and 
differentiating IPMNs from other lesions, MRI is generally 
known to show a better diagnostic performance than MDCT 
(4). However, the lack of communication with the main 
pancreatic duct does not exclude the possibility of an IPMN. 
Features predictive of invasive carcinoma in IPMN on CT 
Fig. 5. 47-year-old woman with lymphoepithelial cyst manifesting as unilocular cyst.
A. Transverse contrast enhanced CT image during arterial phase shows unilocular cystic lesion in tail of pancreas (white arrow). B. Endoscopic US 
image shows homogeneous echoic cystic lesion. C. Surgical specimen shows round tumor with surrounding fibrous capsule (white arrow).
A B C
Fig. 6. 27-year-old woman with mucinous cystic neoplasm manifesting as multilocular cystic lesion (smooth shape with 
septation).
A. Contrast enhanced CT image during venous phase obtained after intravenous injection of contrast material reveals smooth-shaped cystic 
lesion in tail of pancreas. B. Axial T2-weighted MR image reveals multiple internal septa in cystic lesion. C. Endoscopic US image also depicts 
multilocular cystic lesion with smooth shape and multiple inner septa, which was consistent with mucinous cystic neoplasm.
A B C
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and other imaging studies include involvement of the main 
pancreatic duct, marked dilatation of the main pancreatic 
duct, diffuse or multifocal involvement, the presence of a 
large mural nodule or solid mass, large size of the mass, and 
obstruction of the common bile duct (Fig. 9) (11).
Endoscopic US is helpful in excluding a pseudocyst to 
Fig. 7. 37-year-old woman with serous cystadenoma manifesting as multilocular cystic lesion (lobulated).
A. Contrast-enhanced CT image during venous phase shows multilocular cyst in body of pancreas. Lobulated shape of tumor corresponds to 
polycystic serous cystadenoma rather than mucinous cystadenoma. B. Endoscopic US depicts tumor composed of multiple cysts. Endoscopic US-
guided aspiration showed no malignant cell. C. Ill-defined multilocular cystic tumor with inner smooth and trabeculated surface is seen in gross 
specimen (white arrows) and confirmed as serous cystadenoma composed of variable sized cysts lined by simple cuboidal cells.
A B C
Fig. 8. 43-year-old man with branch duct type intraductal papillary mucinous neoplasm manifesting as multilocular cystic lesion 
(pleomorphic cystic).
A. Contrast enhanced CT image during venous phase shows multilocular pleomorphic cystic lesion in head of pancreas. B. Note dilated 
downstream pancreatic duct (black arrow). C. Gross specimen showing ill-defined multilocular cystic tumor in head of pancreas (black arrow) 
which contained mucinous material. Tumor connects with irregularly dilated branches of pancreatic duct, and is confirmed as branch duct type 
intraductal papillary mucinous neoplasm.
A B C
Fig. 9. 52-year-old man with invasive intraductal papillary mucinous neoplasm.
A. Contrast-enhanced CT image during venous phase shows dilatation of main pancreatic duct with adjacent solid mass in head of pancreas (white 
arrows). B. Endoscopic US image shows cystic lesion with inner solid portion (white arrow). C. Surgical specimen shows tumor involvement of 
dilated main pancreatic duct (white arrow). Microscopic examination revealing invasive intraductal papillary mucinous neoplasm.
A B C
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determine the specific type of the cystic pancreatic tumors, 
and identifying a malignant transformation by evaluation of 
the cyst wall (thickness, focal irregularity, mass, or papillary 
projections) and intracystic structures (septations, mucous, 
or debris). EUS features that correlate with malignancy 
include the presence of focal cyst wall thickening or 
irregularity, septal thickening, an adjacent solid mass, and 
the presence of collateral vessels (12).
Microcystic Lesions
Serous microcystic cystadenoma is the only cystic lesion 
included in this category. The typical CT appearance of 
this tumor is similar to that of a sponge or honeycomb 
with innumerable tiny cystic spaces septated by thin 
septa. The septa may coalesce into a characteristic central 
stellate scar that may calcify itself, which is considered to 
be pathognomonic for serous cystadenoma and found in 
about 20% of tumors. The small size of the cysts and the 
innumerable enhancing septa may cause the mass to appear 
solid on CT. Microcysts may be seen as numerous discrete 
foci with bright signal intensity on T2-weighted MR images 
(Fig. 10), and have little free fluid in the locules on EUS (5, 
10, 12, 13).
Limitations and Pitfalls in the Differentiation 
of the Cystic Pancreatic Tumors
Although MCN usually manifests itself as a multilocular 
cyst with a smooth contour, with or without septation, 
there is definite overlap between MCN and serous 
cystadenoma. In our case (Fig. 11), the cystic tumor in the 
tail of the pancreas has a lobulated contour with internal 
septation and calcification in the central area, but it was 
confirmed as MCN (Fig. 11). 
Serous cystadenomas typically have a polycystic, 
honeycomb, or oligocystic appearance. However, they can 
also atypically show giant tumors with ductal dilatation, 
intratumoral hemorrhages, solid variants, unilocular cystic 
tumors, interval growth, and disseminated forms, so that 
imaging findings may be unlikely to be diagnostic (14). 
Even though almost all serous cystic pancreatic neoplasms 
are benign, serous cystadenocarcinomas rarely are benign, 
but also have been reported (15).
Identification of a pleomorphic cyst that communicates 
with the main pancreatic duct is highly suggestive of a 
branch duct type or combined type IPMN. However, the 
lack of communication with the main pancreatic duct does 
not exclude an IPMN. EUS and EUS-guided fine needle 
aspiration (FNA) may provide additional information about 
the malignant transformation. A three-dimensional MR 
Fig. 10. 66-year-old man with microcystic serous cystadenoma manifesting as 
microcystic lesion.
A. Contrast-enhanced transverse CT during arterial phase shows hypervascular mass (white 
arrow) in tail of pancreas. It appears as solid lesion on CT, owing to innumerable cysts and fine 
septa. B. Note cystic portion in periphery of tumor (white arrow). C. Axial T2-weighted image 
reveals microcystic mass. D. Gross specimen shows multilocular, well-defined bulging mass 
containing multiple tiny cystic spaces and sanguineous clear fluid (white arrow), which are 
confirmed as microcystic serous cystadenoma.
A
D
B C
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pancreatography can be used for differentiation of IPMN 
from other pancreatic cystic lesions by showing ductal 
communication (16) (Fig. 12).
CONCLUSION
Pancreatic tumors can be classified by morphologic 
features on CT and their pathologic features are correlated 
Fig. 11. 37-year-old woman with mucinous cystic neoplasm: pitfall in differentiating 
multilocular cystic lesions.
A. Contrast-enhanced CT image during venous phase shows multilocular lobulated cyst with 
internal septation and calcification in tail of pancreas. B. Coronal T2-weighted image reveals 
multilocular cystic mass. C. T1-weighted gradient-echo image shows multiple locules with 
different signal intensity (black and white arrows). D. Gross specimen shows multilocular cystic 
tumor with inner smooth and glistening surface (white arrow) which was confirmed as mucinous 
cystadenoma at microscopy.
A
D
B C
Fig. 12. 59-year-old-woman with branch duct type intraductal papillary mucinous 
neoplasm manifesting as mixed cystic and solid lesion.
A. Contrast-enhanced CT image during venous phase shows cystic mass and internal solid portion 
in head of pancreas (white arrow). B. Two-dimensional thick slab MR cholangiopancreatography 
image shows cystic mass in head of pancreas. Communication between cystic mass and 
pancreatic duct is not clear. C. Source image of 3D-MR cholangiopancreatography shows 
narrow tumor neck suggesting communication between tumor and main pancreatic duct more 
clearly than 2D-MR cholangiopancreatography (white arrow). D. Gross specimen shows whitish 
polypoid friable mass containing translucent mucoid materials. Tumor communicates with main 
pancreatic duct (white arrow) and was confirmed as branch duct type intraductal papillary 
mucinous neoplasm.
A
D
B C
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with CT. Each category has a different malignant potential. 
Therefore, knowledge of the spectrum of morphologic 
features observed in pancreatic tumors is useful for 
differential diagnosis and treatment planning. EUS and 
MRI can provide detailed information for classifying the 
pancreatic lesions.
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